{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:42:12Z","timestamp":1763037732198},"reference-count":30,"publisher":"Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Abstract is missing (Short communication)<\/jats:p>","DOI":"10.2340\/actadv.v102.888","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T07:49:04Z","timestamp":1651650544000},"page":"adv00728","source":"Crossref","is-referenced-by-count":1,"title":["COVID-19 Vaccination Safety in Patients who have had SARS-CoV-2-induced Chilblains"],"prefix":"10.2340","volume":"102","author":[{"given":"Florence","family":"Poizeau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Triquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Dupuy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"key":"19238","doi-asserted-by":"crossref","unstructured":"Freeman E, McMahon D, Lipoff J, Rosenbach M, Kovarik C, Takeshita J, et al. Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries. J Am Acad Dermatol 2020; 83: 486-492.","DOI":"10.1016\/j.jaad.2020.05.109"},{"key":"19239","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2020.05.109","DOI":"10.1016\/j.jaad.2020.05.109"},{"key":"19240","doi-asserted-by":"crossref","unstructured":"Le Cleach L, Dousset L, Assier H, Fourati S, Barbarot S, Boulard C, et al. Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing. Br J Dermatol 2020; 183: 866-874.","DOI":"10.1111\/bjd.19377"},{"key":"19241","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.19377","DOI":"10.1111\/bjd.19377"},{"key":"19242","doi-asserted-by":"crossref","unstructured":"Fernandez-Nieto D, Jimenez-Cauhe J, Suarez-Valle A, Moreno-Arrones OM, Saceda-Corralo D, Arana-Raja A, et al. Characterization of acute acral skin lesions in nonhospitalized patients: a case series of 132 patients during the COVID-19 outbreak. J Am Acad Dermatol 2020; 83: e61-63.","DOI":"10.1016\/j.jaad.2020.04.093"},{"key":"19243","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2020.04.093","DOI":"10.1016\/j.jaad.2020.04.093"},{"key":"19244","doi-asserted-by":"crossref","unstructured":"Galv\u00e1n Casas C, Catal\u00e0 A, Carretero Hern\u00e1ndez G, Rodr\u00edguez-Jim\u00e9nez P, Fern\u00e1ndez-Nieto D, Rodr\u00edguez-Villa Lario A, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 2020; 183: 71-77.","DOI":"10.1111\/bjd.19163"},{"key":"19245","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.19163","DOI":"10.1111\/bjd.19163"},{"key":"19246","doi-asserted-by":"crossref","unstructured":"Piccolo V, Bassi A, Russo T, Mazzatenta C, Baraldi M, Argenziano G, et al. Chilblain-like lesions and COVID-19: second wave, second outbreak. J Eur Acad Dermatol Venereol 2021; 35: e316-e318.","DOI":"10.1111\/jdv.17145"},{"key":"19247","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.17145","DOI":"10.1111\/jdv.17145"},{"key":"19248","doi-asserted-by":"crossref","unstructured":"Hubiche T, Cardot-Leccia N, Le Duff F, Seitz-Polski B, Giordana P, Chiaverini C, et al. Clinical, laboratory, and interferon-alpha response characteristics of patients with chilblain-like lesions during the COVID-19 pandemic. JAMA Dermatol 2021; 157: 202-206.","DOI":"10.1001\/jamadermatol.2020.4324"},{"key":"19249","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.4324","DOI":"10.1001\/jamadermatol.2020.4324"},{"key":"19250","doi-asserted-by":"crossref","unstructured":"Poizeau F, Oger E, Barbarot S, Le Corre Y, Samimi M, Brenaut E, et al. Chilblains during lockdown are associated with household exposure to SARS-CoV-2. A multicentre case-control study. Clin Microbiol Infect 2022; 28: 285-291.","DOI":"10.1016\/j.cmi.2021.09.032"},{"key":"19251","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.cmi.2021.09.032","DOI":"10.1016\/j.cmi.2021.09.032"},{"key":"19252","doi-asserted-by":"crossref","unstructured":"Ortega-Quijano D, Fernandez-Nieto D, Jimenez-Cauhe J, Cortes-Cuevas JL, Marcos-Mencia D, Rodriguez-Dominguez M, et al. Association between COVID-19 and chilblains: a case-control study. J Eur Acad Dermatol Venereol 2021; 35: e359-e361.","DOI":"10.1111\/jdv.17195"},{"key":"19253","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.17195","DOI":"10.1111\/jdv.17195"},{"key":"19254","doi-asserted-by":"crossref","unstructured":"McMahon DE, Amerson E, Rosenbach M, Lipoff JB, Moustafa D, Tyagi A, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol 2021; 85: 46-55.","DOI":"10.1016\/j.jaad.2021.03.092"},{"key":"19255","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2021.03.092","DOI":"10.1016\/j.jaad.2021.03.092"},{"key":"19256","doi-asserted-by":"crossref","unstructured":"Grieco T, Maddalena P, Sernicola A, Muharremi R, Basili S, Alvaro D, et al. Cutaneous adverse reactions after COVID-19 vaccines in a cohort of 2740 Italian subjects: An observational study. Dermatol Ther 2021; 34: e15153.","DOI":"10.1111\/dth.15153"},{"key":"19257","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/dth.15153","DOI":"10.1111\/dth.15153"},{"key":"19258","doi-asserted-by":"crossref","unstructured":"Piccolo V, Bassi A, Argenziano G, Mazzatenta C, Cutrone M, Neri I, et al. BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2. J Eur Acad Dermatology Venereol 2021; 35: e493-e494.","DOI":"10.1111\/jdv.17320"},{"key":"19259","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.17320","DOI":"10.1111\/jdv.17320"},{"key":"19260","doi-asserted-by":"crossref","unstructured":"Poizeau F, Barbarot S, Le Corre Y, Brenaut E, Samimi M, Aubert H, et al. The long-term outcome of patients with chilblains associated with SARS-CoV-2. Acta Derm Venereol 2021; 101: adv00614.","DOI":"10.2340\/00015555-3930"},{"key":"19261","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2340\/00015555-3930","DOI":"10.2340\/00015555-3930"},{"key":"19262","doi-asserted-by":"crossref","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med 2020; 383: 2603-2615.","DOI":"10.1056\/NEJMoa2034577"},{"key":"19263","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJMoa2034577","DOI":"10.1056\/NEJMoa2034577"},{"key":"19264","doi-asserted-by":"crossref","unstructured":"McMahon DE, Kovarik CL, Damsky W, Rosenbach M, Lipoff JB, Tyagi A, et al. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: a registry-based study. J Am Acad Dermatol 2022; 86: 113-121.","DOI":"10.1016\/j.jaad.2021.09.002"},{"key":"19265","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2021.09.002","DOI":"10.1016\/j.jaad.2021.09.002"},{"key":"19266","doi-asserted-by":"crossref","unstructured":"Moghadam P, Frumholtz L, Jaume L, De Masson A, Jachiet M, Begon E, et al. Frequency of relapse and persistent cutaneous symptoms after a first episode of chilblain-like lesion during the COVID-19 pandemic. J Eur Acad Dermatol Venereol 2021; 35: e566-e568.","DOI":"10.1111\/jdv.17393"},{"key":"19267","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.17393","DOI":"10.1111\/jdv.17393"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/888\/5315","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/888\/5316","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/888\/5315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T17:18:44Z","timestamp":1655918324000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":30,"URL":"https:\/\/doi.org\/10.2340\/actadv.v102.888","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,9]]}}}